Bath & Body Works, Inc. (BBWI)
5 Stocks Liked by Brokers Amid the Prevalent Uncertain Scenario
Amid market uncertainty, five broker-favored stocks, CBRL, BBY, BZH, CLF and BBWI, stand out for earnings performance, growth initiatives & favorable valuations.
Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains? (Revised)
Bath & Body Works (BBWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BBWI's Product Innovation Supports Pricing as Consumers Seek Value
Bath & Body Works is leaning on upgraded formulas, packaging and new fragrances to support pricing as value-conscious consumers pressure broader sales.
Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains?
Bath & Body Works (BBWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Which Companies Are Screaming ‘Take Me Private'? These 3 Fit the Bill
Buyout sponsors hunt for cash flow, equity discounts, and operational levers that management left on the table.
BBWI Stock Jumps 7.5% on Q2 Earnings Beat, Fiscal 2026 Outlook Raised
Bath & Body Works stock surges 7.5% after a Q2 earnings beat, stronger direct sales and a higher FY'26 outlook signal improving momentum.
Bath & Body Works: Market Expectations Are Set Too Low
Bath & Body Works, Inc. reported volatile Q2 earnings. Weak store sales continue to pressure the company's earnings power. There were positive signals in BBWI's results as well. Ecommerce sales improved, international & wholesale revenues grew very well, and the FY2026 guidance was raised slightly. Market expectations have been set at an overly pessimistic level. I estimate BBWI stock to have 54% upside to $29.10.
Here's What Key Metrics Tell Us About Bath & Body Works (BBWI) Q2 Earnings
Although the revenue and EPS for Bath & Body Works (BBWI) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bath & Body Works: The Market Is Ignoring This Turnaround Story - For Now
Bath & Body Works, Inc. remains a Strong Buy, with valuation deeply discounted despite improving fundamentals and robust cash flow. Q2 saw adjusted EPS up 67.6% and guidance raised, with management targeting $650 million in free cash flow and $250 million in cost savings. BBWI's balance sheet is strengthening through debt repayments and cash generation, positioning it for future buybacks and further expansion.
Bath & Body Works Q2 Earnings Call Highlights
Bath & Body Works NYSE: BBWI reported second-quarter results that exceeded its prior outlook, though sales remained under pressure as the retailer invests in product innovation, marketing, digital capabilities and expanded distribution to support a planned return to revenue growth in 2027.
Bath & Body Works results top expectations, lower third quarter earnings expected
Bath & Body Works Inc (NYSE:BBWI) on Wednesday reported second quarter fiscal 2026 results above expectations, while the company also raised its full-year adjusted earnings outlook. The retailer reported net sales of $1.51 billion for the quarter ended August 1, down 2.3% from $1.55 billion a year earlier and slightly above analyst expectations of approximately $1.50 billion.
Bath & Body Works (BBWI) Q2 Earnings and Revenues Surpass Estimates
Bath & Body Works (BBWI) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.37 per share a year ago.
